価格表

在庫・価格 : 2025年06月23日 19時38分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-CFH IgG, Human, ELISA Kit
データシート
KA1477 ABNアブノヴァ
Abnova Corporation
1 kit ¥95,000
(未発注)
追加

在庫・価格 : 2025年06月23日 19時38分 現在

Anti-CFH IgG, Human, ELISA Kit

  • 商品コード:KA1477
  • メーカー:ABN
  • 包装:1kit
  • 価格: ¥95,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Lee JM et al. Atypical hemolytic uremic syndrome: Korean pediatric series. Pediatr Int 2014 Dec;
Lee JM et al
2014/01/01
PubMed
2 Zhang C et al. Complement factor H and susceptibility to major depressive disorder in Han Chinese. Br J Psychiatry 2016 May;208(5):446-52
Zhang C et al
2016/01/01
PubMed
3 Y端ksel S et al. First-Line, Early and Long-Term Eculizumab Therapy in Atypical Hemolytic Uremic Syndrome: A Case Series in Pediatric Patients. Paediatr Drugs 2016 Dec;18(6):413-420
Y端ksel S et al
2016/01/01
PubMed
4 Besbas N et al. Turkish pediatric atypical hemolytic uremic syndrome registry: initial analysis of 146 patients. BMC Nephrol 2017 Jan;18(1):6
Besbas N et al
2017/01/01
PubMed
5 Fujisawa M et al. Clinical characteristics and genetic backgrounds of Japanese patients with atypical hemolytic uremic syndrome. Clin. Exp. Nephrol. 2018 Mar;
Fujisawa M et al
2018/01/01
PubMed
6 Fidan K et al. Extra-Renal manifestations of atypical hemolytic uremic syndrome in children. Pediatr. Nephrol. 2018 Aug;33(8):1395-1403
Fidan K et al
2018/01/01
PubMed
7 Tseng MH et al. Whole-exome sequencing detects mutations in pediatric patients with atypical hemolytic uremic syndrome in Taiwan. Clin. Chim. Acta 2019 Jul;494:143-150
Tseng MH et al
2019/01/01
PubMed
8 Nakayama S et al. Atypical reduction of plasma ADAMTS13 activity by a non-IgG-type inhibitor in a patient with hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli. CEN Case Rep 2019 11;8(4):266-270
Nakayama S et al
2019/01/01
PubMed
9 Fujisawa M et al. The role of anti-complement factor H antibodies in the development of atypical haemolytic uremic syndrome: a possible contribution to abnormality of platelet function. Br. J. Haematol. 2020 Apr;189(1):182-186
Fujisawa M et al
2020/01/01
PubMed
10 Y端ksel S et al. Renal Biopsy Prognostic Findings in Children With Atypical Hemolytic Uremic Syndrome. Pediatr Dev Pathol ;23(5):362-371
Y端ksel S et al
PubMed
11 Tseng MH et al. Serum complement factor I is associated with disease activity of systemic lupus erythematosus. Oncotarget 2018 Feb;9(9):8502-8511
Tseng MH et al
2018/01/01
PubMed
  • No.: 1
  • 文献情報:
    Lee JM et al. Atypical hemolytic uremic syndrome: Korean pediatric series. Pediatr Int 2014 Dec;
    Lee JM et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Zhang C et al. Complement factor H and susceptibility to major depressive disorder in Han Chinese. Br J Psychiatry 2016 May;208(5):446-52
    Zhang C et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Y端ksel S et al. First-Line, Early and Long-Term Eculizumab Therapy in Atypical Hemolytic Uremic Syndrome: A Case Series in Pediatric Patients. Paediatr Drugs 2016 Dec;18(6):413-420
    Y端ksel S et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Besbas N et al. Turkish pediatric atypical hemolytic uremic syndrome registry: initial analysis of 146 patients. BMC Nephrol 2017 Jan;18(1):6
    Besbas N et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Fujisawa M et al. Clinical characteristics and genetic backgrounds of Japanese patients with atypical hemolytic uremic syndrome. Clin. Exp. Nephrol. 2018 Mar;
    Fujisawa M et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Fidan K et al. Extra-Renal manifestations of atypical hemolytic uremic syndrome in children. Pediatr. Nephrol. 2018 Aug;33(8):1395-1403
    Fidan K et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Tseng MH et al. Whole-exome sequencing detects mutations in pediatric patients with atypical hemolytic uremic syndrome in Taiwan. Clin. Chim. Acta 2019 Jul;494:143-150
    Tseng MH et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Nakayama S et al. Atypical reduction of plasma ADAMTS13 activity by a non-IgG-type inhibitor in a patient with hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli. CEN Case Rep 2019 11;8(4):266-270
    Nakayama S et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Fujisawa M et al. The role of anti-complement factor H antibodies in the development of atypical haemolytic uremic syndrome: a possible contribution to abnormality of platelet function. Br. J. Haematol. 2020 Apr;189(1):182-186
    Fujisawa M et al
    2020/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Y端ksel S et al. Renal Biopsy Prognostic Findings in Children With Atypical Hemolytic Uremic Syndrome. Pediatr Dev Pathol ;23(5):362-371
    Y端ksel S et al
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Tseng MH et al. Serum complement factor I is associated with disease activity of systemic lupus erythematosus. Oncotarget 2018 Feb;9(9):8502-8511
    Tseng MH et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed